Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) Tumor Protein p73 Antikörper:
anti-Human Tumor Protein p73 Antikörper:
anti-Mouse (Murine) Tumor Protein p73 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal Tumor Protein p73 Primary Antibody für ChIP, CyTOF - ABIN4343232
Shimodaira, Yoshioka-Yamashita, Kolodner, Wang: Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. in Proceedings of the National Academy of Sciences of the United States of America 2003
Show all 53 Pubmed References
Human Monoclonal Tumor Protein p73 Primary Antibody für ChIP, ICC - ABIN252619
Costanzo, Merlo, Pediconi, Fulco, Sartorelli, Cole, Fontemaggi, Fanciulli, Schiltz, Blandino, Balsano, Levrero: DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. in Molecular cell 2002
Show all 28 Pubmed References
Human Polyclonal Tumor Protein p73 Primary Antibody für IHC (p), IP - ABIN151880
Levy, Adamovich, Reuven, Shaul: The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. in Cell death and differentiation 2007
Show all 13 Pubmed References
Human Monoclonal Tumor Protein p73 Primary Antibody für IP, WB - ABIN967629
Jost, Marin, Kaelin: p73 is a simian [correction of human] p53-related protein that can induce apoptosis. in Nature 1997
Show all 5 Pubmed References
Human Polyclonal Tumor Protein p73 Primary Antibody für IHC (p), WB - ABIN3043469
Qin, Nan, Yang, Jing, Ruan, Li, Xu, Guo, Sui, Wei: Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma. in World journal of gastroenterology 2005
Show all 2 Pubmed References
Human Monoclonal Tumor Protein p73 Primary Antibody für GS, ICC - ABIN269466
King, Reddi, Ponnamperuma, Gerdes, Weinberg: Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding. in Molecular carcinogenesis 2014
Human Monoclonal Tumor Protein p73 Primary Antibody für WB - ABIN252620
Shao, Tanaka, Gribi, Yu: Thioredoxin-related regulation of NO/NOS activities. in Annals of the New York Academy of Sciences 2002
Human Polyclonal Tumor Protein p73 Primary Antibody für IHC - ABIN966779
Yuan, Shioya, Ishiko, Sun, Gu, Huang, Lu, Kharbanda, Weichselbaum, Kufe: p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. in Nature 1999
Human Polyclonal Tumor Protein p73 Primary Antibody für IP, WB - ABIN538288
Zhu, Jiang, Zhou, Chen: The potential tumor suppressor p73 differentially regulates cellular p53 target genes. in Cancer research 1998
Show all 3 Pubmed References
Human Polyclonal Tumor Protein p73 Primary Antibody für IF (p), IHC (p) - ABIN675279
Liu, Yang, Jing, Ren, Wei, Zhang, Zhang, Duan, Zhou, Sun: Silica nanoparticle exposure inducing granulosa cell apoptosis and follicular atresia in female Balb/c mice. in Environmental science and pollution research international 2018
Binding of TAp73 to the ATP7A promoter occurs in non-small cell lung carcinoma cells.
The data show that the expression level of TAp73 is critical for the sensitivity towards DNA crosslinking agents in melanoma cells, which is most likely independent of p53 activity.
DNp73-induced degradation of tyrosinase links depigmentation with epithelial mesenchymal transformation-driven melanoma progression.
p73 is a positive regulator of a cell adhesion related gene named integrin beta4 (ITGB4).
c-Jun N-terminal kinase (JNK) phosphorylation of mutant and wild-type tumor protein p53 (p53) promotes the formation of a p53/tumor protein p73 (p73) complex that determines cell fate: apoptosis.
the apoptotic regulator p73 also coordinates with Delta133p53 to promote DNA DSB repair.
Structure determination of the transactivation domains of p63 and p73 in complex with the p300 Taz2 domain further revealed that, in contrast to p53 and p73, p63 has a single transactivation domain.
TP73 G4C14-A4T14 polymorphism causes an upgrade cancer risk, especially in Caucasian population. G4C14-A4T14 polymorphism might be a potential biomarker for judging the tumorigenesis of cervical cancer and colorectal cancer.
The transcriptional activity of p73 is regulated by acetylation of the lysine residues located in the C-terminal region.SIRT2-mediated inactivation of p73 is critical for the proliferation and tumorigenicity of glioblastoma cells.
TopBP1 transcriptional activity is regulated by AKT, and treatment with AKT inhibitors suppresses expression of E2F1 and p73 without interfering with ATR signaling.
TAp73 deficiency results in a pronounced reduction in tumorigenic potential, which can be rescued by forced PFKL expression.
cytoplasmic apoptotic function of p73 is mediated through a noncanonical mode of Bcl-XL recognition
TP73-AS1 overlaps with TP73 in a tail-to-tail configuration with an overlap length of 216 nt.
high levels of Np73 stabilize HIF-1alpha protein, allowing for it to accumulate and further potentiating its transcriptional activity and supporting tumor progression.
Knockdown of tumor protein p73 (TAp73) in tumor suppressor p53 (p53)-/- cells using CRISPR/Cas9 significantly prolonged the duration of resistance.
miR647 functions as a tumor promoter in Gastric Cancer by repressing TP73.
Data show that codon usage bias (CUB) was moderate in P73 gene and the percentage of mean C was the highest followed by G. The gene variants were GC rich. The GC-ending codons showed increasing usage with increasing GC3 while AT-ending codons showed the opposite with increasing GC3 bias. ATA and AGA were absent among the synonymous codons in P73 gene. Both mutation pressure and natural selection might influence the CUB.
NQO1 is a FAD-dependent, two-domain multifunctional stress protein acting as a Phase II enzyme, activating cancer pro-drugs and stabilizing p53 and p73a oncosuppressors.tructural protein:protein interaction studies reveal that the cancer-associated polymorphism does not abolish the interaction with p73alpha, indicating that oncosuppressor destabilization largely mirrors the low intracellular stability of p.P187S.
Tumor protein p73 (TAp73) and kallmann syndrome 1 sequence protein (KAI1) expression levels are positively correlated in colorectal cancer.
the present study verified a novel molecular link between miRNA663b and TP73, and indicated that miRNA663b may be a critical therapeutic target in breast cancer.
p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton.
Results suggest that the loss of tumor suppressor protein p73 (p73) during the embryonic period is critical for hydrocephalus development.
Current understanding indicates that various products from TP73 genes, originated by alternative gene promoter usage and differential splicing, might differentially participate in complex networks that regulate cell growth, differentiation and death. TAp73alpha is found as the exclusive, or major, expressed isoform in most of the biological system analyzed. [review]
p73 exerts its functions in neuronal biology at least partially through the regulation of metabolic pathways.
Data (including data from studies in knockout/transgenic mice) suggest Ppp2ca supports cortical neuronal growth and cognitive function via regulating p73/Gls2 signal transduction in neurons of hippocampus. Ppp2ca gene knock-out results in embryonic cortical atrophy with learning/memory deficits. (Ppp2ca = protein phosphatase 2a catalytic subunit alpha isoform; p73 = transformation related protein 73; Gls2 = glutaminase-2)
p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming.
P73 role in differentiating stem cells.RASSF1A promotes a YAP-p73 transcriptional programme that enables differentiation.
Absence of TAp73 leads to activation of TGF-beta signaling through a Sma and Mad-related proteins-independent pathway, favoring oncogenic transforming growth factor-beta effects and epithelial-to-mesenchymal transition.
Findings reinforce the role of TAp73 as tumor suppressor gene and indicate that the regulation of cellular metabolism by TAp73 contributes to its tumor suppressor function.
cells expressing both p63 and p73 exist in mouse epidermis and hair follicle and that hetero-tetramer complexes can be detected by immunoprecipitation in differentiating keratinocytes.
both p53 and p73 are critical in apoptosis induced by DNA damage and differentiation.
New function of p73, independent of p53, in the neurogenic architecture of the SVZ of rodent brain.
these results therefore highlight an unanticipated role for p53 family proteins in a regulatory network that integrates essential Wnt-Tcf and nodal-Smad inputs.
TAp73 as necessary and sufficient for basal body docking, axonemal extension, and motility during the differentiation of Motile multiciliated cell progenitors.
p73 drives multiciliogenesis, both through transcriptional activation of a master ciliogenesis transcription factor FoxJ1 and through regulation of multiple genes central to ciliogenesis.
The p73 acts as a critical regulator of multiciliogenesis in its capacity as a sequence-specific transcription factor, through genomic binding and regulation of genes.
Data show that the Mdm4-p73 axis cannot override the dominant role of p53 in development and tumorigenesis and that Mdm4 and p73 interaction during development and tumorigenesis suggests new insight into the role of p53 family members.
In vivo inhibition of both p63 and p73 in combination accelerates tumor regression and increases survival of p53-deficient mice.
Results indicate that p73 regulates basal and starvation-induced fuel metabolism in the liver, a finding that is likely to be highly relevant for metabolism-associated disorders, such as diabetes and cancer.
cDNA and amino acid sequences; characterization of expression pattern during fish development as well as in some adult tissues
This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined.
transformation related protein 73
, tumor protein p73
, tumor protein p73-like
, p53-like transcription factor
, p53-related protein